Related references
Note: Only part of the references are listed.Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells
Kristian M. Hargadon et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
Y-C Wu et al.
ONCOGENE (2016)
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms An Opportunity for Identification of High-risk Disease
Eran Sadot et al.
ANNALS OF SURGERY (2015)
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)
Mario E. Lacouture et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
MDSC and TGF Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes
A. A. Shvedova et al.
CANCER RESEARCH (2015)
The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor- receptor on dendritic cells potentiates tumour antigen-specific CD8+ T cell immunity
Y. -H. Ahn et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2
Raquel Rodrigues-Diez et al.
MEDIATORS OF INFLAMMATION (2015)
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT
Junlong Zhuang et al.
SCIENTIFIC REPORTS (2015)
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Panagiotis Papageorgis
JOURNAL OF ONCOLOGY (2015)
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
V. De Simone et al.
ONCOGENE (2015)
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
Yijie Chen et al.
BIOLOGICAL RESEARCH (2015)
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
Qing-Min Fan et al.
CANCER LETTERS (2014)
NK Cells Are the Crucial Antitumor Mediators When STAT3-Mediated Immunosuppression Is Blocked in Hepatocellular Carcinoma
Qiangjun Sui et al.
JOURNAL OF IMMUNOLOGY (2014)
Summary of bi-shRNA(furin)/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG (TM)) in Advanced Cancer of the Liver
John Nemunaitis et al.
ONCOLOGY (2014)
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Meixiao Shen et al.
PLOS ONE (2014)
T-cell TGF-β signaling abrogation restricts medulloblastoma progression
David Gate et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells
Sarah S. Donatelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation
Muly Tham et al.
ONCOTARGET (2014)
Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
Camila Maria Longo Machado et al.
CANCER MEDICINE (2014)
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy
L. Zhang et al.
GENE THERAPY (2013)
Breast cancer-derived transforming growth factor- and tumor necrosis factor- compromise interferon- production by tumor-associated plasmacytoid dendritic cells
Vanja Sisirak et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer
Ji-Won Kim et al.
CANCER RESEARCH AND TREATMENT (2013)
Tumor-altered dendritic cell function: implications for anti-tumor immunity
Kristian M. Hargadon
FRONTIERS IN IMMUNOLOGY (2013)
Immunological efects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
James P. Stevenson et al.
ONCOIMMUNOLOGY (2013)
Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer
Galina V. Shurin et al.
CANCER MICROENVIRONMENT (2013)
Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells
Helen Conroy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer
Juan R. Cubillos-Ruiz et al.
CANCER RESEARCH (2012)
Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
Vanja Sisirak et al.
CANCER RESEARCH (2012)
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
Uciane K. Scarlett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cell-Intrinsic Abrogation of TGF-β Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer
Cassie K. Chou et al.
JOURNAL OF IMMUNOLOGY (2012)
Dendritic Cell-Specific Disruption of TGF-β Receptor II Leads to Altered Regulatory T Cell Phenotype and Spontaneous Multiorgan Autoimmunity
Rajalakshmy Ramalingam et al.
JOURNAL OF IMMUNOLOGY (2012)
TGF-β - an excellent servant but a bad master
Lenka Kubiczkova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Phase I Trial of bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell Vaccine (FANG) in Advanced Cancer
Neil Senzer et al.
MOLECULAR THERAPY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
Dinja Oosterhoff et al.
ONCOIMMUNOLOGY (2012)
A Poised Chromatin Platform for TGF-β Access to Master Regulators
Qiaoran Xi et al.
CELL (2011)
Novel TGF-β Antagonist Inhibits Tumor Growth and Angiogenesis by Inducing IL-2 Receptor-Driven STAT1 Activation
Claudia Penafuerte et al.
JOURNAL OF IMMUNOLOGY (2011)
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Hiroshi Kurahara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
Melissa G. Lechner et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma
Bi Cheng Zhang et al.
MEDICAL ONCOLOGY (2011)
TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth
T. J. Standiford et al.
ONCOGENE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
Rao H. Prabhala et al.
BLOOD (2010)
Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression
Panagiotis Papageorgis et al.
CANCER RESEARCH (2010)
Translational Mini-Review Series on Th17 Cells: Development of mouse and human T helper 17 cells
E. de Jong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Mesenchymal Stem Cells Protect Breast Cancer Cells through Regulatory T Cells: Role of Mesenchymal Stem Cell-Derived TGF-β
Shyam A. Patel et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells
Donggou He et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-10/TGF-β-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis
Qi Cao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
T(H)17 cells in tumour immunity and immunotherapy
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses
Yufeng Xie et al.
CANCER RESEARCH (2009)
Inflammatory signals in dendritic cell activation and the induction of adaptive immunity
Olivier Joffre et al.
IMMUNOLOGICAL REVIEWS (2009)
Induction of myeloid-derived suppressor cells by tumor exosomes
Xiaoyu Xiang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The Tale of Transforming Growth Factor-Beta (TGF beta) Signaling: A Soigne Enigma
Arindam Chaudhury et al.
IUBMB LIFE (2009)
TNF-α induces TGF-β1expression in lung fibroblasts at the transcriptional levelviaAP-1 activation
Deborah E. Sullivan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients
Jing-Ping Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T Cells
Ingrid E. Dumitriu et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Transcriptional regulation of the TGF-β1 promoter by androgen receptor
Wei Qi et al.
BIOCHEMICAL JOURNAL (2008)
Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Vaccination with transforming growth factor-beta insensitive dendritic cells suppresses pulmonary metastases of renal carcinoma in mice
Feng Tian et al.
CANCER LETTERS (2008)
Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy
Samuel Kim et al.
CANCER RESEARCH (2008)
Cutting edge:: Autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cells
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2008)
Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells
Yi Qun Xiao et al.
JOURNAL OF IMMUNOLOGY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis
Yasmina Laouar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
TGF-β insensitive dendritic cells:: an efficient vaccine for murine prostate cancer
Fu-Li Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Blockade of TGF-β accelerates mucosal destruction through epithelial cell apoptosis
Hirotake Sakuraba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cells
Prathibha Ranganathan et al.
BMC GENOMICS (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription
Sarah Ross et al.
EMBO JOURNAL (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
Ming O. Li et al.
IMMUNITY (2006)
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor
Julien C. Marie et al.
IMMUNITY (2006)
Blockade of transforming growth factor-β signaling in tumor-reactive CD8+ T cells activates the antitumor immune response cycle
Qiang Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinoma
Shi-Long Lu et al.
GENES & DEVELOPMENT (2006)
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-β receptor
K Lacuesta et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-β1
I Kinjyo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma
SQ Wang et al.
BLOOD (2006)
Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells
Q Zhang et al.
PROSTATE (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Elevated plasma TGF-beta(1) levels correlate with decreased survival of metastatic breast cancer patients
Vesna Ivanovic et al.
CLINICA CHIMICA ACTA (2006)
NF-kappa B and activator protein 1 response elements and the role of histone modifications in IL-1-beta-induced TGF-beta 1 gene transcription
KY Lee et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of NK cell activity through TGF-β1 by down-regulation of NKG2D in a murine model of head and neck cancer
S Dasgupta et al.
JOURNAL OF IMMUNOLOGY (2005)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
VEGF induces proliferation, migration, and TGF-β1 expression in mouse glomerular endothelial cells via mitogen-activated protein kinase and phosphatidylinositol 3-kinase
ZD Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Adoptive transfer of tumor-reactive transforming growth factor-β-insensitive CD8+ T cells:: Eradication of autologous mouse prostate cancer
Q Zhang et al.
CANCER RESEARCH (2005)
Overexpression of the TGF-β antagonist Smad7 in endometrial cancer
SC Dowdy et al.
GYNECOLOGIC ONCOLOGY (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance
A Zippelius et al.
CANCER RESEARCH (2004)
Soluble type II transforming growth factor-β receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Expression of transforming growth factor β in renal cell carcinoma and matched non-involved renal tissue
D Mitropoulos et al.
UROLOGICAL RESEARCH (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-β1 synthesis via an autocrine PDGF loop
D Fraser et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients:: Role of common γ-chain cytokines
A Anichini et al.
JOURNAL OF IMMUNOLOGY (2003)
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
TGF β1 expression and angiogenesis in colorectal cancer tissue
B Xiong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
ML Albert et al.
NATURE IMMUNOLOGY (2001)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β
K Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
How cells read TGF-β signals
J Massagué
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Cyclin A down-regulation in TGFβ1-arrested follicular lymphoma cells
R Djaborkhel et al.
EXPERIMENTAL CELL RESEARCH (2000)
Requirement of Ras/MAPK pathway activation by transforming growth factor ß for transforming growth factor ß1 production in a Smad-dependent pathway
JB Yue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
